FDA Elevates Nationwide Blood Pressure Medication Recall to Class II Due to Dissolution Issues

The FDA has classified an ongoing voluntary recall of certain chlorthalidone 25 mg tablets, used to treat high blood pressure, as a Class II recall. This recall, involving over 13,000 bottles from one lot, is due to failed dissolution specifications, meaning the medication may not dissolve properly and could be less effective. A Class II recall indicates that exposure to the recalled product may cause temporary or medically reversible health issues, with a remote probability of serious consequences.